Adjunctive nutritional approaches can change depression treatment outcomes by enhancing response rates, reducing residual symptoms, and addressing biological pathways that conventional antidepressants may not fully target. The World Health Organization recognizes depression as a leading cause of disability worldwide, which increases interest in scalable, low-risk interventions that complement pharmacotherapy and psychotherapy. Evidence from clinical trials and syntheses highlights dietary pattern changes, omega-3 fatty acids, and targeted micronutrient supplementation as the most-studied adjuncts, although effects vary by formulation, baseline nutrition, and socio-cultural context.
Clinical evidence and quality of trials
The SMILES randomized trial led by Felice Jacka Deakin University showed that a structured Mediterranean-style dietary intervention produced clinically meaningful symptom reductions compared with an active control, demonstrating that dietary change can be an effective adjunct for some patients. Meta-analyses and systematic reviews including work by Michael Berk Deakin University report modest benefits for EPA-predominant omega-3 fatty acids when used alongside antidepressants, particularly for depressive symptoms rather than prevention. Jerome Sarris Western Sydney University and colleagues have highlighted that multi-nutrient formulas and folate derivatives show promise as adjuncts in specific subgroups, while trials for vitamin D and single-nutrient interventions often yield heterogeneous results. The overall quality of evidence ranges from high for some dietary interventions to mixed for isolated supplements, emphasizing the importance of rigorous randomized controlled trials.
Mechanisms, relevance, and broader consequences
Biological mechanisms plausibly connecting nutrition to mood include modulation of inflammation, neurotransmitter synthesis, neuroplasticity, and the gut microbiota. Michael Berk Deakin University has emphasized inflammation as a mediator linking poor diet to depressive symptoms. Clinically, adjunctive nutritional therapies can improve treatment response and reduce chronicity for patients with partial response to standard care, with implications for reduced disability and healthcare utilization. Culturally, dietary interventions must respect local foodways and affordability; populations facing food insecurity may be least able to adopt recommended changes, potentially widening health disparities. Environmentally, reliance on marine-derived omega-3s raises sustainability concerns that intersect with territorial fisheries and indigenous food practices. Overall, adjunctive nutritional strategies are a valuable component of personalized depression care but require careful selection, monitoring, and consideration of social and ecological contexts to maximize benefit. Further high-quality, diverse trials are needed to refine who benefits most and how best to implement these approaches in routine practice.